Hi TB ,
but that is what Rohan said at the meeting.
They will have data at the end of 25 in both P11 & ADOA to validate that it does work , and that the platform has the ability to tackle other eye diseases..
So i dont believe it is at the "early" stage at all.
As I said in other post , Rohan said at the meeting , that they could take it to market , so i dont believe a low ball offer would be entertained .
As you said , its in the billions 'annually "...
for years and years and years....
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.020(1.59%) |
Mkt cap ! $743.6M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.28 | $1.24 | $46.67K | 37.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15857 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |